These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 20129535)

  • 1. Accuracy of optical coherence tomography in the evaluation of neointimal coverage after stent implantation.
    Murata A; Wallace-Bradley D; Tellez A; Alviar C; Aboodi M; Sheehy A; Coleman L; Perkins L; Nakazawa G; Mintz G; Kaluza GL; Virmani R; Granada JF
    JACC Cardiovasc Imaging; 2010 Jan; 3(1):76-84. PubMed ID: 20129535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation in 3 months duration of neointimal coverage after zotarolimus-eluting stent implantation by optical coherence tomography: the ENDEAVOR OCT trial.
    Kim JS; Jang IK; Fan C; Kim TH; Kim JS; Park SM; Choi EY; Lee SH; Ko YG; Choi D; Hong MK; Jang Y
    JACC Cardiovasc Interv; 2009 Dec; 2(12):1240-7. PubMed ID: 20129551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective randomised study using optical coherence tomography to assess endothelial coverage and neointimal proliferation at 6-months after implantation of a coronary everolimus-eluting stent compared with a bare metal stent postdilated with a paclitaxel-eluting balloon (OCTOPUS Trial): rationale, design and methods.
    Poerner TC; Otto S; Gassdorf J; Janiak F; Danzer C; Ferrari M; Figulla HR
    EuroIntervention; 2011 May; 7 Suppl K():K93-9. PubMed ID: 22027737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Head-to-head comparison of the neointimal response between metallic and bioresorbable everolimus-eluting scaffolds using optical coherence tomography.
    Gomez-Lara J; Brugaletta S; Farooq V; Onuma Y; Diletti R; Windecker S; Thuesen L; McClean D; Koolen J; Whitbourn R; Dudek D; Smits PC; Chevalier B; Regar E; Veldhof S; Rapoza R; Ormiston JA; Garcia-Garcia HM; Serruys PW
    JACC Cardiovasc Interv; 2011 Dec; 4(12):1271-80. PubMed ID: 22192368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of angiographic late loss with neointimal proliferation in stents evaluated by OCT and histology in porcine coronary arteries.
    Kim JS; Wallace-Bradley D; Alviar CL; Conditt G; Milewski K; Afari ME; Cheng Y; Gallego C; Tellez A; Stone GW; Kaluza GL; Granada JF
    JACC Cardiovasc Imaging; 2011 Sep; 4(9):1002-10. PubMed ID: 21920339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preliminary observations using optical coherence tomography to assess neointimal coverage of a metal stent in a porcine model.
    Mills JS; N'diaye CS; Yow E; Urtz M; Povsic TJ; Greenfield JC; Phillips HR
    Cardiovasc Revasc Med; 2009; 10(4):229-35. PubMed ID: 19815170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histological validation of frequency domain optical coherence tomography for the evaluation of neointimal formation after a novel polymer-free sirolimus-eluting stent implantation.
    Fu Q; Hu H; Chen W; Tan Z; Li L; Wang D; Chen B
    Int J Clin Exp Pathol; 2015; 8(9):11068-75. PubMed ID: 26617825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo comparison between optical coherence tomography and intravascular ultrasound for detecting small degrees of in-stent neointima after stent implantation.
    Suzuki Y; Ikeno F; Koizumi T; Tio F; Yeung AC; Yock PG; Fitzgerald PJ; Fearon WF
    JACC Cardiovasc Interv; 2008 Apr; 1(2):168-73. PubMed ID: 19463295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optical coherence tomography assessment of in vivo vascular response after implantation of overlapping bare-metal and drug-eluting stents.
    Guagliumi G; Musumeci G; Sirbu V; Bezerra HG; Suzuki N; Fiocca L; Matiashvili A; Lortkipanidze N; Trivisonno A; Valsecchi O; Biondi-Zoccai G; Costa MA;
    JACC Cardiovasc Interv; 2010 May; 3(5):531-9. PubMed ID: 20488410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment by optical coherence tomography of stent struts across side branch. -Comparison of bare-metal stents and drug-elution stents.-.
    Liu Y; Imanishi T; Kubo T; Tanaka A; Kitabata H; Tanimoto T; Ino Y; Ikejima H; Tsujioka H; Komukai K; Ishibashi K; Kashiwagi M; Ozaki Y; Hirata K; Mizukoshi M; Akasaka T
    Circ J; 2011; 75(1):106-12. PubMed ID: 21041972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different patterns of vascular response between patients with or without diabetes mellitus after drug-eluting stent implantation: optical coherence tomographic analysis.
    Tanaka N; Terashima M; Rathore S; Itoh T; Habara M; Nasu K; Kimura M; Itoh T; Kinoshita Y; Ehara M; Tsuchikane E; Asakura K; Asakura Y; Katoh O; Suzuki T
    JACC Cardiovasc Interv; 2010 Oct; 3(10):1074-9. PubMed ID: 20965467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term follow-up of neointimal coverage of sirolimus-eluting stents--evaluation with optical coherence tomography.
    Ishigami K; Uemura S; Morikawa Y; Soeda T; Okayama S; Nishida T; Takemoto Y; Onoue K; Somekawa S; Takeda Y; Kawata H; Horii M; Saito Y
    Circ J; 2009 Dec; 73(12):2300-7. PubMed ID: 19789417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peri-strut low-intensity areas in optical coherence tomography correlate with peri-strut inflammation and neointimal proliferation: an in-vivo correlation study in the familial hypercholesterolemic coronary swine model of in-stent restenosis.
    Tellez A; Afari ME; Buszman PP; Seifert P; Cheng Y; Milewski K; McGregor JC; Garza JA; Roberts MB; Yi GH; Kaluza GL; Granada JF
    Coron Artery Dis; 2014 Nov; 25(7):595-601. PubMed ID: 25013949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accuracy of OCT in evaluating neointimal thickness after stent implantation.
    Ferrante G; Dimopoulos K; Montone RA; Barlis P
    JACC Cardiovasc Imaging; 2010 Jun; 3(6):669; discussion 669-70. PubMed ID: 20541723
    [No Abstract]   [Full Text] [Related]  

  • 15. Intra- and interobserver reliability and intra-catheter reproducibility using frequency domain optical coherence tomography for the evaluation of morphometric stent parameters and qualitative assessment of stent strut coverage.
    Antonsen L; Thayssen P; Junker A; Veien KT; Hansen HS; Hansen KN; Hougaard M; Jensen LO
    Cardiovasc Revasc Med; 2015 Dec; 16(8):469-77. PubMed ID: 26475731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neointimal coverage on drug-eluting stent struts crossing side-branch vessels using optical coherence tomography.
    Her AY; Lee BK; Shim JM; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
    Am J Cardiol; 2010 Jun; 105(11):1565-9. PubMed ID: 20494663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of neointimal proliferation in stented canine coronary artery with optical coherence tomography].
    Wang JD; Guo J; Tian F; Yang TS; Chen YD
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Nov; 31(11):1855-7. PubMed ID: 22126764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue characterization after drug-eluting stent implantation using optical coherence tomography.
    Malle C; Tada T; Steigerwald K; Ughi GJ; Schuster T; Nakano M; Massberg S; Jehle J; Guagliumi G; Kastrati A; Virmani R; Byrne RA; Joner M
    Arterioscler Thromb Vasc Biol; 2013 Jun; 33(6):1376-83. PubMed ID: 23539216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neointimal coverage of sirolimus-eluting stents 6 months and 12 months after implantation: evaluation by optical coherence tomography.
    Yao ZH; Matsubara T; Inada T; Suzuki Y; Suzuki T
    Chin Med J (Engl); 2008 Mar; 121(6):503-7. PubMed ID: 18364133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative and qualitative changes in DES-related neointimal tissue based on serial OCT.
    Kim JS; Hong MK; Shin DH; Kim BK; Ko YG; Choi D; Jang Y
    JACC Cardiovasc Imaging; 2012 Nov; 5(11):1147-55. PubMed ID: 23153915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.